Skip to main content

SENESCENCIA Y PLASTICIDAD CELULARES: FUNCION EN REPARACION TISULAR Y EN ENFERMEDAD

SAF2017-82613-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACIO INSTITUT DE RECERCA BIOMEDICA (BARCELONA)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Deciphering the roadmap of in vivo reprogramming toward pluripotency

  • Chondronasiou, Dafni
  • Martínez de Villarreal, Jaime
  • Melendez, Elena
  • Lynch, Cian J.
  • Del Pozo, Natalia
  • Kovatcheva, Marta
  • Aguilera, Mònica
  • Prats, Neus
  • Real, Francisco X.
  • Serrano, Manuel
Differentiated cells can be converted into pluripotent stem cells by expressing the transcription factors OCT4, SOX2, KLF4, and MYC (OSKM) in a process known as reprogramming. Here, using single-cell RNA sequencing of pancreas undergoing reprogramming, we identify markers along the trajectory from acinar cell identity to pluripotency. These markers allow direct in situ visualization of cells undergoing dedifferentiation and acquiring features of early and advanced intermediate reprogramming. We also find that a fraction of cells do not dedifferentiate upon OSKM expression and are characterized by stress markers of the REG3 and AP-1 families. Importantly, most markers of intermediate reprogramming in the pancreas are also observed in stomach, colon, and cultured fibroblasts expressing OSKM. Among them is LY6A, a protein characteristic of progenitor cells and generally upregulated during tissue repair. Our roadmap defines intermediate reprogramming states that could be functionally relevant for tissue regeneration and rejuvenation., Work in the laboratory of F.X.R. was funded by grants from the Spanish Ministry of Science co-funded by the ERDF-EU (SAF2015-70553-R and RTI2018-101071-B-I00). Work in the laboratory of M.S. was funded by the IRB and by grants from the Spanish Ministry of Science co-funded by the ERDF-EU (SAF2017-82613-R), European Research Council (ERC-2014-AdG/669622), Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282), “la Caixa” Foundation, and the Milky Way Research Foundation. The CNIO and IRB are supported by the Spanish Ministry of Science as Centres of Excellence “Severo Ochoa.”
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Natural killer cells act as an extrinsic barrier for in vivo reprogramming

  • Melendez, Elena
  • Chondronasiou, Dafni
  • Mosteiro, Lluc
  • Martínez de Villarreal, Jaime
  • Fernández-Alfara, Marcos
  • Lynch, Cian J.
  • Grimm, Dirk
  • Real, Francisco X.
  • Alcamí, José
  • Climent, Núria
  • Pietrocola, Federico
  • Serrano, Manuel
The ectopic expression of the transcription factors OCT4, SOX2, KLF4 and MYC (OSKM) enables reprogramming of differentiated cells into pluripotent embryonic stem cells. Methods based on partial and reversible in vivo reprogramming are a promising strategy for tissue regeneration and rejuvenation. However, little is known about the barriers that impair reprogramming in an in vivo context. We report that natural killer (NK) cells significantly limit reprogramming, both in vitro and in vivo. Cells and tissues in the intermediate states of reprogramming upregulate the expression of NK-activating ligands, such as MULT1 and ICAM1. NK cells recognize and kill partially reprogrammed cells in a degranulation-dependent manner. Importantly, in vivo partial reprogramming is strongly reduced by adoptive transfer of NK cells, whereas it is significantly increased by their depletion. Notably, in the absence of NK cells, the pancreatic organoids derived from OSKM-expressing mice are remarkably large, suggesting that ablating NK surveillance favours the acquisition of progenitor-like properties. We conclude that NK cells pose an important barrier for in vivo reprogramming, and speculate that this concept may apply to other contexts of transient cellular plasticity., E.M. was funded by an IRB Future Fellowship from the Institute for Research in Biomedicine (IRB Barcelona). F.P. was funded by a European Molecular Biology Organization Long Term Fellowship (EMBO-ALTF-358-2017). Work in the laboratory of F.P. was funded by a Starting Grant from the Swedish Research Council (Vetenskapsrådet) (VR MH 2019-02050) and by a starting grant from Karolinska Institutet. Work by N.C. was funded by a grant from Fondo de Investigaciones Sanitarias (FIS) (PI20/00676). Work in the laboratory of F.X.R. was funded by a grant from the Ministerio de Ciencia e Innovación co-funded by the European Regional Development Fund (RTI2018-101071-B-I00). Work in the laboratory of J.A. at Hospital Clínic was funded by “la Caixa” Foundation. Work in the laboratory of M.S. was funded by the Institute for Research in Biomedicine and “la Caixa” Foundation, and by grants from the Ministerio de Ciencia e Innovación co-funded by the European Regional Development Fund (SAF2017-82613-R), European Research Council (ERC-2014-AdG/669622), and Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement, Generalitat de Catalunya (Grup de Recerca consolidat 2017 SGR 282). Open Access funding provided by Institute for Research in Biomedicine (IRB Barcelona). Deposited in PMC for immediate release.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

  • Chaib, Selim
  • Arribas, Joaquín
  • Serrano, Manuel
Chemotherapy often generates intratumoral senescent cancer cells that strongly modify the tumor microenvironment, favoring immunosuppression and tumor growth. We discovered, through an unbiased proteomics screen, that the immune checkpoint inhibitor programmed cell death 1 ligand 2 (PD-L2) is highly upregulated upon induction of senescence in different types of cancer cells. PD-L2 is not required for cells to undergo senescence, but it is critical for senescent cells to evade the immune system and persist intratumorally. Indeed, after chemotherapy, PD-L2-deficient senescent cancer cells are rapidly eliminated and tumors do not produce the senescence-associated chemokines CXCL1 and CXCL2. Accordingly, PD-L2-deficient pancreatic tumors fail to recruit myeloid-derived suppressor cells and undergo regression driven by CD8 T cells after chemotherapy. Finally, antibody-mediated blockade of PD-L2 strongly synergizes with chemotherapy causing remission of mammary tumors in mice. The combination of chemotherapy with anti-PD-L2 provides a therapeutic strategy that exploits vulnerabilities arising from therapy-induced senescence., We thank the IRB Core Facilities (Functional Genomics Core, Biostatistics/Bioinformatics and Histopathology), the Parc Científic de Barcelona Animal Facility and the University of Barcelona/Centros Científicos y Tecnológicos de la Universidad de Barcelona Flow Cytometry Facility for their contribution to this work. J.A.L-D. was supported by the Spanish Ministry of Science through a Juan de la Cierva-Incorporación fellowship and by the Asociación Española Contra el Cáncer (AECC) through an AECC Investigador fellowship. I.M. was funded by an FPI fellowship from the Spanish Ministry of Science. Work in the laboratory of M.S. was funded by the IRB and ‘la Caixa’ Foundation, and by grants from the Spanish Ministry of Science cofunded by the European Regional Development Fund (ERDF) (no. SAF2017-82613-R), European Research Council (no. ERC-2014-AdG/669622) and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282). J.L.K., T.T. and S.C. were supported by the National Institutes of Health (grant nos. R37AG13925, R33AG61456, R01AG072301, R01AG61414, P01AG62413 and UH3AG56933), the Connor Fund, Robert J. and Theresa W. Ryan and the Noaber Foundation. A.G. received funding from the Spanish Ministry of Science cofunded by the ERDF (no. RTC-2017-6123-1), from the Instituto de Salud Carlos III (no. MS15/00058) and from CAIMI-II (grant no. 53/2021) supported by the BBVA Foundation. A.G.-G. was the recipient of a PERIS grant (no. SLT017/20/000131) from the Generalitat de Catalunya. The laboratory of M. Abad received funding from the Spanish Ministry of Science and Innovation (nos. RTI2018-102046-B-I00A and RTC-2017-6123-1) and the AECC (no. PRYCO211023SERR). M.A. was the recipient of a Ramón y Cajal contract from the Spanish Ministry of Science and Innovation (no. RYC-2013-14747). O.B. was the recipient of a FPIAGAUR fellowship from Generalitat de Catalunya. Work in the laboratory of J.A. is supported by the Breast Cancer Research Foundation (no. BCRF-21-008), Instituto de Salud Carlos III (project refs. AC15/00062, CB16/12/00449 and PI19/01181) and the European Commission (under the Framework of the ERA-NET TRANSCAN-2 initiative cofinanced by FEDER), AECC and Fundació La Caixa (no. HR22-00776).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Higher circulating vitamin B12 is associated with lower levels of inflammatory markers in individuals at high cardiovascular risk and in naturally aged mice

  • Domínguez-López, Inés
  • Kovatcheva, Marta
  • Casas, Rosa
  • Toledo, Estefania
  • Fitó Colomer, Montserrat
  • Ros, Emilio
  • Estruch, Ramón
  • Serrano, Manuel
  • Lamuela Raventós, Rosa Ma.
Background: Vitamin B12 is an essential nutrient that is involved in numerous physiological processes, and its deficiency can lead to various complications, including neurological and haematological disorders. Some studies have suggested that vitamin B12 may have anti-inflammatory effects, but the mechanisms underlying this relationship are not yet fully understood. We investigated the relationship between circulating vitamin B12 and inflammatory markers interleukin (IL)-6 and C-reactive protein (CRP). The association of peripheral levels of vitamin B12 with IL-6 and CRP was assessed in 136 human samples from a high cardiovascular risk population. To corroborate the results from the human trial, the analysis was replicated in naturally aged mice. Results: Individuals with higher serum levels of vitamin B12 showed lower concentrations of IL-6 and CRP after adjustment for potential confounders, and an inverse association was also found between serum IL-6 and vitamin B12 levels in naturally aged mice. Conclusion: Circulating vitamin B12 was inversely associated with IL-6 and CRP in humans and with IL-6 in mice, suggesting that it may exert an anti-inflammatory effect through modulation of these pro-inflammatory molecules. © 2023 The Authors. Journal of The Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry., This research was partially funded by PID2020-114022RB-I00 and CIBEROBN from the Instituto de Salud Carlos III, ISCIII from the Ministerio de Ciencia, Innovación y Universidades (AEI/FEDER, UE) and Generalitat de Catalunya (GC) [2021-SGR-00334]. INSA-UB is María de Maeztu Unit of Excellence (grant CEX2021-001234-M funded by MICIN/AEI/FEDER, UE). Work in the laboratory of M. Serrano was funded by the IRB and La Caixa Foundation, and by grants from the Spanish Ministry of Science cofunded by the European Regional Development Fund (SAF-2017-82613-R, RTC-2017-6123-1), the European Research Council (ERC-2014-AdG/669622), Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282) and the AECC (PRYCO211023SERR). M. Kovatcheva reports grants from Asociación Española Contra el Cáncer (AECC), the European Research Council and IRB BioMedTec during the conduct of the study, as well as other support from Galapagos NV outside the submitted work. M. Serrano reports grants from the Spanish Ministry of Science, the European Research Council, La Caixa Foundation, the Spanish Association for Cancer Research (AECC) and Departament d'Empresa i Coneixement of Catalonia during the conduct of the study, as well as other support from Senolytic Therapeutics, Inc., Rejuveron Senescence Therapeutics, AG, Life Biosciences, Inc., Altos Labs, Inc. and Galapagos NV, and grants from the Milky Way Research Foundation outside the submitted work. The PREDIMED trial was supported by the official funding agency for biomedical research of the Spanish government (Instituto de Salud Carlos III) through grants provided to research networks specifically developed for the trial: RTIC G03/140 (Coordinator: RE) and RTIC RD 06/0045. All investigators of the PREDIMED trial belong to Centro de Investigación Biomédica en Red (CIBER), an initiative of Instituto de Salud Carlos III. ID-L thanks the Spanish Ministry of Science Innovation and Universities for the Formación de Profesorado Universitario (FPU20/02478) contract.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The trophectoderm acts as a niche for the inner cell mass through C/EBPα-regulated IL-6 signaling

  • Plana Carmona, Marcos, 1993-
  • Stik, Grégoire
  • Bulteau, Romain
  • Segura-Morales, Carolina
  • Alcázar, Noelia
  • Wyatt, Christopher Douglas Robert, 1988-
  • Klonizakis, Antonios
  • Andrés Aguayo, Luisa de
  • Gasnier, Maxime
  • Tian, Tian V.
  • Torcal Garcia, Guillem, 1991-
  • Vila-Casadesús, Maria
  • Plachta, Nicolas
  • Serrano, Manuel
  • Francesconi, Mirko
  • Graf, T. (Thomas)
IL-6 has been shown to be required for somatic cell reprogramming into induced pluripotent stem cells (iPSCs). However, how Il6 expression is regulated and whether it plays a role during embryo development remains unknown. Here, we describe that IL-6 is necessary for C/EBPα-enhanced reprogramming of B cells into iPSCs but not for B cell to macrophage transdifferentiation. C/EBPα overexpression activates both Il6 and Il6ra genes in B cells and in PSCs. In embryo development, Cebpa is enriched in the trophectoderm of blastocysts together with Il6, while Il6ra is mostly expressed in the inner cell mass (ICM). In addition, Il6 expression in blastocysts requires Cebpa. Blastocysts secrete IL-6 and neutralization of the cytokine delays the morula to blastocyst transition. The observed requirement of C/EBPα-regulated IL-6 signaling for pluripotency during somatic cell reprogramming thus recapitulates a physiologic mechanism in which the trophectoderm acts as niche for the ICM through the secretion of IL-6., Work in the laboratory of T.G. was supported by the Spanish Ministry of Economy, Industry and Competitiveness (Plan Estatal PID2019-109354GB-I00), the CRG, AGAUR (SGR 726), and a European Research Council Synergy grant (4D-Genome). M.P.-C. was supported by an FPI fellowship (BES-2016-076900). Work in the laboratory of M.S. was funded by the IRB and by grants from the Spanish Ministry of Economy co-funded by the European Regional Development Fund (SAF2017-82613-R), ERC (ERC-2014-AdG/669622), la Caixa Foundation, and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cellular senescence limits acute lung injury induced by mechanical ventilation

  • Blázquez-Prieto, Jorge
  • Huidobro, Covadonga
  • López-Alonso, Inés
  • Amado-Rodríguez, Laura
  • Martín-Vicente, Paula
  • López-Martínez, Cecilia
  • Crespo, Irene
  • Pantoja, Cristina
  • Fernández-Marcos, Pablo José
  • Serrano, Manuel
  • Sznajder, Jacob I.
  • Albaiceta, Guillermo M.
Different forms of lung injury can activate senescence pathways. Senescence has been involved in chronic lung diseases, but its role in the acute phase is less known. Acute lung injury activates a large variety of pathogenetic mechanisms that can lead to respiratory insufficiency. In some cases, mechanical ventilation may help to maintain gas exchange, but positive airway pressures can cause regional overdistension of alveolar units and further damage. Here, we report that acute lung injury and alveolar overstretching activate a lung senescent program aimed to limit apoptosis. A systematic pooling of transcriptomic data from animal models of lung injury demonstrates the enrichment of a specific senescence signature. In a clinically relevant, murine model of acid aspiration and mechanical ventilation, we observed the activation of the Tp53/Cdkn1a (p21) senescence pathway, increases in senescence-associated heterochromatin foci in alveolar cells and markers of DNA damage, chromatin reorganization and changes in the nuclear envelope. Autopsy samples from lungs of critically ill patients showed the increase in senescence-associated heterochromatin foci. Cell stretch per se was also able to activate the senescence response in an ex-vivo model. Absence of Cdkn1a decreased the senescent response, but worsened lung injury by a significant increase in apoptosis. In opposite, treatment with lopinavir/ritonavir led to Cdkn1a overexpression and ameliorated cell apoptosis and lung injury. Collectively, these results suggest that acute injury promotes lung senescence. This response plays a protective role against acute lung injury in the short term, but its long-term consequences remain unexplored., Supported by grants from Centro de Investigación Biomédica en Red (CIBER) and Instituto de Salud Carlos III. LAR is the recipient of a grant from Instituto de Salud Carlos III (CM16/00128). CHF is the recipient of a grant from Instituto de Salud Carlos III (CD16/00033). Instituto Universitario de Oncología del Principado de Asturias is supported by a grant from Fundación Cajastur-Liberbank. Work in the laboratory of M.S. was funded by the IRB, by “La Caixa” Foundation, and by grants from the Spanish Ministry of Economy co-funded by the European Regional Development Fund (ERDF) (SAF2017-82613-R) and from the European Research Council (ERC-2014-AdG/669622)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Global hyperactivation of enhancers stabilizes human and mouse naive pluripotency through inhibition of CDK8/19 mediator kinases

  • Lynch, Cian J.
  • Bernad, Raquel
  • Martínez-Val, Ana
  • Shahbazi, Marta N.
  • Nóbrega-Pereira, Sandrina
  • Calvo, Isabel
  • Blanco-Aparicio, Carmen
  • Tarantino, Carolina
  • Garreta, Elena
  • Richart-Ginés, Laia
  • Alcazar, Noelia
  • Graña-Castro, Osvaldo
  • Gómez-López, Gonzalo
  • Aksoy, Irene
  • Muñoz-Martín, Maribel
  • Martinez, Sonia
  • Ortega, Sagrario
  • Prieto, Susana
  • Simboeck, Elisabeth
  • Camasses, Alain
  • Stephan-Otto Attolini, Camille
  • Fernández, Agustín F.
  • Sierra, Marta I.
  • Fraga, Mario F.
  • Pastor, Joaquín
  • Fisher, Daniel
  • Montserrat, Núria
  • Savatier, Pierre
  • Muñoz, Javier
  • Zernicka-Goetz, Magdalena
  • Serrano, Manuel
Pluripotent stem cells (PSCs) transition between cell states in vitro, reflecting developmental changes in the early embryo. PSCs can be stabilized in the naive state by blocking extracellular differentiation stimuli, particularly FGF–MEK signalling. Here, we report that multiple features of the naive state in human and mouse PSCs can be recapitulated without affecting FGF–MEK signalling or global DNA methylation. Mechanistically, chemical inhibition of CDK8 and CDK19 (hereafter CDK8/19) kinases removes their ability to repress the Mediator complex at enhancers. CDK8/19 inhibition therefore increases Mediator-driven recruitment of RNA polymerase II (RNA Pol II) to promoters and enhancers. This efficiently stabilizes the naive transcriptional program and confers resistance to enhancer perturbation by BRD4 inhibition. Moreover, naive pluripotency during embryonic development coincides with a reduction in CDK8/19. We conclude that global hyperactivation of enhancers drives naive pluripotency, and this can be achieved in vitro by inhibiting CDK8/19 kinase activity. These principles may apply to other contexts of cellular plasticity., M.N.S. was funded by a Leverhulme Trust early career fellowship. Work in the laboratory of M.Z.-G. was funded by the Wellcome Trust (098287/Z/12/Z) and the European Research Council (ERC) (669198). I.C. was funded by the Secretaria d’Universitats i Recerca de la Generalitat de Catalunya and European Social Fund. I.A. and P.S. were supported by the Fondation pour la Recherche Medicale (DEQ20170336757), Infrastructure Nationale en Biologie et Santé INGESTEM (ANR-11-INBS-0009), IHU-B CESAME (ANR-10-IBHU-003), LabEx REVIVE (ANR-10-LABX-73), LabEx DEVweCAN (ANR-10-LABX-0061) and LabEx CORTEX (ANR-11-LABX-0042) of University of Lyon within the programme ‘Investissements d’Avenir’ (ANR-11-IDEX-0007). Research by J.P., S.M. and C.B.-A. was supported in part by a grant from the Spanish Ministry of Economy and Competitiveness (SAF2013-44267-R) and by the CNIO. Work in the laboratory of D.F. was funded by the Institut National du Cancer (PLBIO10-068 and PLBIO15-005) and the Ligue National Contre le Cancer (EL2018.LNCC/DF). Work in the laboratory of N.M. was funded by the ERC, under the European Union Horizon 2020 research and innovation programme (StG-2014–640525_REGMAMKID), the Spanish Association Against Cancer (AECC/LABAE16006), Carlos III Health Institute (Red TerCel, CardioCel, RD16/0011/0027), Ministry of Economy and Competitiveness (MINECO) projects SAF2017–89782-R, SAF2015–72617-EXP and RYC-2014–16242, and the CERCA/Government of Catalonia (2017 SGR 1306). Work in the laboratory of S.O. was funded by SAF2013–44866-R from MINECO Spain. Work in the laboratory of M.F.F. was funded by Plan Nacional de I+D+I 2013–2016/FEDER (PI15/00892, to M.F.F. and A.F.F.); the ISCIII-Subdireccion General de Evaluación y Fomento de la Investigación and Plan Nacional de I+D+I 2008–2011/FEDER (CP11/00131, to A.F.F.); IUOPA (to M.I.S.); and the Asturias Regional Government (GRUPIN14–052, to M.F.F.). The IUOPA is supported by the Obra Social Liberbank-Cajastur, Spain. Work in the laboratory of M.S. was funded by the CNIO, the IRB and by grants from Spanish Ministry of Economy co-funded by the European Regional Development Fund (SAF2017-82613-R), ERC (ERC-2014-AdG/669622), Botin Foundation, Banco Santander (Santander Universities Global Division), laCaixa Foundation and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Induction of Lysosome Membrane Permeabilization as a Therapeutic Strategy to Target Pancreatic Cancer Stem Cells

  • Cash, Timothy P.
  • Alcalá, Sonia
  • Rico-Ferreira, María del Rosario
  • Hernández Encinas, María Elena
  • García, Jennifer
  • Albarrán, María Isabel
  • Valle, Sandra
  • Muñoz, Javier
  • Martínez-González, Sonia
  • Blanco-Aparicio, Carmen
  • Pastor, Joaquín
  • Serrano, Manuel
  • Sainz, Bruno Jr.
Despite significant efforts to improve pancreatic ductal adenocarcinoma (PDAC) clinical outcomes, overall survival remains dismal. The poor response to current therapies is partly due to the existence of pancreatic cancer stem cells (PaCSCs), which are efficient drivers of PDAC tumorigenesis, metastasis and relapse. To find new therapeutic agents that could efficiently kill PaCSCs, we screened a chemical library of 680 compounds for candidate small molecules with anti-CSC activity, and identified two compounds of a specific chemical series with potent activity in vitro and in vivo against patient-derived xenograft (PDX) cultures. The anti-CSC mechanism of action of this specific chemical series was found to rely on induction of lysosomal membrane permeabilization (LMP), which is likely associated with the increased lysosomal mass observed in PaCSCs. Using the well characterized LMP-inducer siramesine as a tool molecule, we show elimination of the PaCSC population in mice implanted with tumors from two PDX models. Collectively, our approach identified lysosomal disruption as a promising anti-CSC therapeutic strategy for PDAC., This study was financially supported by a Ramón y Cajal Merit Award (RYC-2012-12104) from the Ministerio de Economía y Competitividad, Spain (B.S.Jr.); funding from The Fero Foundation (B.S.Jr.); a Coordinated grant from the Fundación Asociación Española Contra el Cáncer (AECC) GC16173694BARB (B.S.,Jr.); Fondo de Investigaciones Sanitarias (FIS) grant PI15/01507 and PI18/00757 (B.S.,Jr.), (co-financed through Fondo Europeo de Desarrollo Regional (FEDER) “Una manera de hacer Europa”). ETP activities were supported by funds of The Spanish National Cancer Research Centre (CNIO). Work in the laboratory of M.S. was funded by the CNIO, the IRB and “laCaixa” Foundation, and by grants from the Spanish Ministry of Economy co-funded by the European Regional Development Fund (ERDF) (SAF2017-82613-R), the European Research Council (ERC-2014-AdG/669622) and, Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dual-Specificity Phosphatase 1 (DUSP1) Has a Central Role in Redox Homeostasis and Inflammation in the Mouse Cochlea

  • Bermúdez-Muñoz, Jose Mª
  • Celaya, Adelaida M.
  • García-Mato, Ángela
  • Muñoz-Espín, Daniel
  • Rodriguez-de la Rosa, Lourdes
  • Serrano, Manuel
  • Varela-Nieto, Isabel
This article belongs to the Special Issue Oxidative Stress and Inflammation in Deafness: Current and Future Therapy., Stress-activated protein kinases (SAPK) are associated with sensorineural hearing loss (SNHL) of multiple etiologies. Their activity is tightly regulated by dual-specificity phosphatase 1 (DUSP1), whose loss of function leads to sustained SAPK activation. Dusp1 gene knockout in mice accelerates SNHL progression and triggers inflammation, redox imbalance and hair cell (HC) death. To better understand the link between inflammation and redox imbalance, we analyzed the cochlear transcriptome in Dusp1−/− mice. RNA sequencing analysis (GSE176114) indicated that Dusp1−/− cochleae can be defined by a distinct profile of key cellular expression programs, including genes of the inflammatory response and glutathione (GSH) metabolism. To dissociate the two components, we treated Dusp1−/− mice with N-acetylcysteine, and hearing was followed-up longitudinally by auditory brainstem response recordings. A combination of immunofluorescence, Western blotting, enzymatic activity, GSH levels measurements and RT-qPCR techniques were used. N-acetylcysteine treatment delayed the onset of SNHL and mitigated cochlear damage, with fewer TUNEL+ HC and lower numbers of spiral ganglion neurons with p-H2AX foci. N-acetylcysteine not only improved the redox balance in Dusp1−/− mice but also inhibited cytokine production and reduced macrophage recruitment. Our data point to a critical role for DUSP1 in controlling the cross-talk between oxidative stress and inflammation, This work was funded by FEDER/B2017/BMD-3688-MULTITARGET&VIEWCM and 0551-PSL-6-E NITROPROHEAR grants to I.V.-N., J.M.B.-M., Á.G.-M. and L.R.-d.l.R. held SAF2017-HEARCODE, FPU (FPU16/03308; MECD) and CIBERER (Institute of Health Carlos III) contracts, respectively, co-financed with FEDER funds. Work by D.M.-E. and M.S. was funded by grant SAF2017-82613-R from the Spanish Ministry of Science co-funded by the European Regional Development Fund (ERDF). Work in the laboratory of M.S. was also funded by the IRB and “laCaixa” Foundation, and by grants from the European Research Council (ERC-2014-AdG/669622), and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282. D.M.-E. laboratory is supported by the Cancer Research UK (CRUK) Cambridge Centre Early Detection Programme (RG86786), by a CRUK Programme Foundation Award (C62187/A29760), by a CRUK Early Detection OHSU Project Award (C62187/A26989), and by a Medical Research Council (MRC) New Investigator Research Grant (NIRG) (MR/R000530/1).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Stability of imprinting and differentiation capacity in naïve human cells induced by chemical inhibition of CDK8 and CDK19

  • Bernad, Raquel
  • Lynch, Cian J.
  • Urdinguio, Rocío G.
  • Stephan-Otto Attolini, Camille
  • Fraga, Mario F.
  • Serrano, Manuel
This article belongs to the Special Issue Transcriptional and Epigenetic Regulation of Pluripotency and Differentiation., Pluripotent stem cells can be stabilized in vitro at different developmental states by the use of specific chemicals and soluble factors. The naïve and primed states are the best characterized pluripotency states. Naïve pluripotent stem cells (PSCs) correspond to the early pre-implantation blastocyst and, in mice, constitute the optimal starting state for subsequent developmental applications. However, the stabilization of human naïve PSCs remains challenging because, after short-term culture, most current methods result in karyotypic abnormalities, aberrant DNA methylation patterns, loss of imprinting and severely compromised developmental potency. We have recently developed a novel method to induce and stabilize naïve human PSCs that consists in the simple addition of a chemical inhibitor for the closely related CDK8 and CDK19 kinases (CDK8/19i). Long-term cultured CDK8/19i-naïve human PSCs preserve their normal karyotype and do not show widespread DNA demethylation. Here, we investigate the long-term stability of allele-specific methylation at imprinted loci and the differentiation potency of CDK8/19i-naïve human PSCs. We report that long-term cultured CDK8/19i-naïve human PSCs retain the imprinting profile of their parental primed cells, and imprints are further retained upon differentiation in the context of teratoma formation. We have also tested the capacity of long-term cultured CDK8/19i-naïve human PSCs to differentiate into primordial germ cell (PGC)-like cells (PGCLCs) and trophoblast stem cells (TSCs), two cell types that are accessible from the naïve state. Interestingly, long-term cultured CDK8/19i-naïve human PSCs differentiated into PGCLCs with a similar efficiency to their primed counterparts. Also, long-term cultured CDK8/19i-naïve human PSCs were able to differentiate into TSCs, a transition that was not possible for primed PSCs. We conclude that inhibition of CDK8/19 stabilizes human PSCs in a functional naïve state that preserves imprinting and potency over long-term culture., Work in the laboratory of M.F.F. was funded by the Spanish Association Against Cancer (PROYE18061FERN to M.F.F.), the Asturias Government (PCTI) co-funding 2018-2022/FEDER (IDI/2018/146 to M.F.F.), Fundación General CSIC (0348_CIE_6_E to M.F.F.) and the Health Institute Carlos III (Plan Nacional de I+D+I) co-funding FEDER (PI18/01527 to M.F.F). R.G.U. is supported by the Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER). We also acknowledge support from the IUOPA-ISPA-FINBA (the IUOPA is supported by the Obra Social Cajastur-Liberbank, Spain). Work in the laboratory of M.S. was funded by the IRB and by grants from the Spanish Ministry of Economy co-funded by the European Regional Development Fund (SAF2017-82613-R), ERC (ERC-2014-AdG/669622), Banco Santander (Santander Universities Global Division), la Caixa Foundation, and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The trophectoderm acts as a niche for the inner cell mass through C/EBPα-regulated IL-6 signaling

  • Plana Carmona, Marcos, 1993-
  • Stik, Grégoire
  • Bulteau, Romain
  • Segura-Morales, Carolina
  • Alcázar, Noelia
  • Wyatt, Christopher Douglas Robert, 1988-
  • Klonizakis, Antonios
  • Andrés Aguayo, Luisa de
  • Gasnier, Maxime
  • Tian, Tian V.
  • Torcal Garcia, Guillem, 1991-
  • Vila-Casadesús, Maria
  • Plachta, Nicolas
  • Serrano, Manuel
  • Francesconi, Mirko
  • Graf, T. (Thomas)
IL-6 has been shown to be required for somatic cell reprogramming into induced pluripotent stem cells (iPSCs). However, how Il6 expression is regulated and whether it plays a role during embryo development remains unknown. Here, we describe that IL-6 is necessary for C/EBPα-enhanced reprogramming of B cells into iPSCs but not for B cell to macrophage transdifferentiation. C/EBPα overexpression activates both Il6 and Il6ra genes in B cells and in PSCs. In embryo development, Cebpa is enriched in the trophectoderm of blastocysts together with Il6, while Il6ra is mostly expressed in the inner cell mass (ICM). In addition, Il6 expression in blastocysts requires Cebpa. Blastocysts secrete IL-6 and neutralization of the cytokine delays the morula to blastocyst transition. The observed requirement of C/EBPα-regulated IL-6 signaling for pluripotency during somatic cell reprogramming thus recapitulates a physiologic mechanism in which the trophectoderm acts as niche for the ICM through the secretion of IL-6., Work in the laboratory of T.G. was supported by the Spanish Ministry of Economy, Industry and Competitiveness (Plan Estatal PID2019-109354GB-I00), the CRG, AGAUR (SGR 726), and a European Research Council Synergy grant (4D-Genome). M.P.-C. was supported by an FPI fellowship (BES-2016-076900). Work in the laboratory of M.S. was funded by the IRB and by grants from the Spanish Ministry of Economy co-funded by the European Regional Development Fund (SAF2017-82613-R), ERC (ERC-2014-AdG/669622), la Caixa Foundation, and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2

  • Chaib, Selim
  • Arribas, Joaquín
  • Serrano, Manuel
Chemotherapy often generates intratumoral senescent cancer cells that strongly modify the tumor microenvironment, favoring immunosuppression and tumor growth. We discovered, through an unbiased proteomics screen, that the immune checkpoint inhibitor programmed cell death 1 ligand 2 (PD-L2) is highly upregulated upon induction of senescence in different types of cancer cells. PD-L2 is not required for cells to undergo senescence, but it is critical for senescent cells to evade the immune system and persist intratumorally. Indeed, after chemotherapy, PD-L2-deficient senescent cancer cells are rapidly eliminated and tumors do not produce the senescence-associated chemokines CXCL1 and CXCL2. Accordingly, PD-L2-deficient pancreatic tumors fail to recruit myeloid-derived suppressor cells and undergo regression driven by CD8 T cells after chemotherapy. Finally, antibody-mediated blockade of PD-L2 strongly synergizes with chemotherapy causing remission of mammary tumors in mice. The combination of chemotherapy with anti-PD-L2 provides a therapeutic strategy that exploits vulnerabilities arising from therapy-induced senescence., We thank the IRB Core Facilities (Functional Genomics Core, Biostatistics/Bioinformatics and Histopathology), the Parc Científic de Barcelona Animal Facility and the University of Barcelona/Centros Científicos y Tecnológicos de la Universidad de Barcelona Flow Cytometry Facility for their contribution to this work. J.A.L-D. was supported by the Spanish Ministry of Science through a Juan de la Cierva-Incorporación fellowship and by the Asociación Española Contra el Cáncer (AECC) through an AECC Investigador fellowship. I.M. was funded by an FPI fellowship from the Spanish Ministry of Science. Work in the laboratory of M.S. was funded by the IRB and ‘la Caixa’ Foundation, and by grants from the Spanish Ministry of Science cofunded by the European Regional Development Fund (ERDF) (no. SAF2017-82613-R), European Research Council (no. ERC-2014-AdG/669622) and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282). J.L.K., T.T. and S.C. were supported by the National Institutes of Health (grant nos. R37AG13925, R33AG61456, R01AG072301, R01AG61414, P01AG62413 and UH3AG56933), the Connor Fund, Robert J. and Theresa W. Ryan and the Noaber Foundation. A.G. received funding from the Spanish Ministry of Science cofunded by the ERDF (no. RTC-2017-6123-1), from the Instituto de Salud Carlos III (no. MS15/00058) and from CAIMI-II (grant no. 53/2021) supported by the BBVA Foundation. A.G.-G. was the recipient of a PERIS grant (no. SLT017/20/000131) from the Generalitat de Catalunya. The laboratory of M. Abad received funding from the Spanish Ministry of Science and Innovation (nos. RTI2018-102046-B-I00A and RTC-2017-6123-1) and the AECC (no. PRYCO211023SERR). M.A. was the recipient of a Ramón y Cajal contract from the Spanish Ministry of Science and Innovation (no. RYC-2013-14747). O.B. was the recipient of a FPIAGAUR fellowship from Generalitat de Catalunya. Work in the laboratory of J.A. is supported by the Breast Cancer Research Foundation (no. BCRF-21-008), Instituto de Salud Carlos III (project refs. AC15/00062, CB16/12/00449 and PI19/01181) and the European Commission (under the Framework of the ERA-NET TRANSCAN-2 initiative cofinanced by FEDER), AECC and Fundació La Caixa (no. HR22-00776).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Deciphering the roadmap of in vivo reprogramming toward pluripotency

  • Chondronasiou, Dafni
  • Martínez de Villarreal, Jaime
  • Melendez, Elena
  • Lynch, Cian J.
  • Del Pozo, Natalia
  • Kovatcheva, Marta
  • Aguilera, Mònica
  • Prats, Neus
  • Real, Francisco X.
  • Serrano, Manuel
Differentiated cells can be converted into pluripotent stem cells by expressing the transcription factors OCT4, SOX2, KLF4, and MYC (OSKM) in a process known as reprogramming. Here, using single-cell RNA sequencing of pancreas undergoing reprogramming, we identify markers along the trajectory from acinar cell identity to pluripotency. These markers allow direct in situ visualization of cells undergoing dedifferentiation and acquiring features of early and advanced intermediate reprogramming. We also find that a fraction of cells do not dedifferentiate upon OSKM expression and are characterized by stress markers of the REG3 and AP-1 families. Importantly, most markers of intermediate reprogramming in the pancreas are also observed in stomach, colon, and cultured fibroblasts expressing OSKM. Among them is LY6A, a protein characteristic of progenitor cells and generally upregulated during tissue repair. Our roadmap defines intermediate reprogramming states that could be functionally relevant for tissue regeneration and rejuvenation., Work in the laboratory of F.X.R. was funded by grants from the Spanish Ministry of Science co-funded by the ERDF-EU (SAF2015-70553-R and RTI2018-101071-B-I00). Work in the laboratory of M.S. was funded by the IRB and by grants from the Spanish Ministry of Science co-funded by the ERDF-EU (SAF2017-82613-R), European Research Council (ERC-2014-AdG/669622), Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282), “la Caixa” Foundation, and the Milky Way Research Foundation. The CNIO and IRB are supported by the Spanish Ministry of Science as Centres of Excellence “Severo Ochoa.”
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Natural killer cells act as an extrinsic barrier for in vivo reprogramming

  • Melendez, Elena
  • Chondronasiou, Dafni
  • Mosteiro, Lluc
  • Martínez de Villarreal, Jaime
  • Fernández-Alfara, Marcos
  • Lynch, Cian J.
  • Grimm, Dirk
  • Real, Francisco X.
  • Alcamí, José
  • Climent, Núria
  • Pietrocola, Federico
  • Serrano, Manuel
The ectopic expression of the transcription factors OCT4, SOX2, KLF4 and MYC (OSKM) enables reprogramming of differentiated cells into pluripotent embryonic stem cells. Methods based on partial and reversible in vivo reprogramming are a promising strategy for tissue regeneration and rejuvenation. However, little is known about the barriers that impair reprogramming in an in vivo context. We report that natural killer (NK) cells significantly limit reprogramming, both in vitro and in vivo. Cells and tissues in the intermediate states of reprogramming upregulate the expression of NK-activating ligands, such as MULT1 and ICAM1. NK cells recognize and kill partially reprogrammed cells in a degranulation-dependent manner. Importantly, in vivo partial reprogramming is strongly reduced by adoptive transfer of NK cells, whereas it is significantly increased by their depletion. Notably, in the absence of NK cells, the pancreatic organoids derived from OSKM-expressing mice are remarkably large, suggesting that ablating NK surveillance favours the acquisition of progenitor-like properties. We conclude that NK cells pose an important barrier for in vivo reprogramming, and speculate that this concept may apply to other contexts of transient cellular plasticity., E.M. was funded by an IRB Future Fellowship from the Institute for Research in Biomedicine (IRB Barcelona). F.P. was funded by a European Molecular Biology Organization Long Term Fellowship (EMBO-ALTF-358-2017). Work in the laboratory of F.P. was funded by a Starting Grant from the Swedish Research Council (Vetenskapsrådet) (VR MH 2019-02050) and by a starting grant from Karolinska Institutet. Work by N.C. was funded by a grant from Fondo de Investigaciones Sanitarias (FIS) (PI20/00676). Work in the laboratory of F.X.R. was funded by a grant from the Ministerio de Ciencia e Innovación co-funded by the European Regional Development Fund (RTI2018-101071-B-I00). Work in the laboratory of J.A. at Hospital Clínic was funded by “la Caixa” Foundation. Work in the laboratory of M.S. was funded by the Institute for Research in Biomedicine and “la Caixa” Foundation, and by grants from the Ministerio de Ciencia e Innovación co-funded by the European Regional Development Fund (SAF2017-82613-R), European Research Council (ERC-2014-AdG/669622), and Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement, Generalitat de Catalunya (Grup de Recerca consolidat 2017 SGR 282). Open Access funding provided by Institute for Research in Biomedicine (IRB Barcelona). Deposited in PMC for immediate release.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Iron accumulation drives fibrosis, senescence and the senescence-associated secretory phenotype

  • Maus, Mate
  • López Polo, Vanessa
  • Mateo, Lidia
  • Lafarga, Miguel
  • Aguilera, Mònica
  • De Lama, Eugenia
  • Meyer, Kathleen
  • SOLA, ANNA
  • Lopez-Martinez, Cecilia
  • López-Alonso, Ines
  • Guasch-Piqueras, Marc
  • Hernandez-Gonzalez, Fernanda
  • Chaib, Selim
  • Rovira, Miguel
  • Sanchez-Fernandez, Mayka
  • Faner, Rosa
  • Agusti, Alvar
  • Diéguez-Hurtado, Rodrigo
  • Ortega, Sagrario
  • Manonelles, Anna
  • Engelhardt, Stefan
  • Monteiro, Freddy
  • Stephan-Otto Attolini, Camille
  • Prats, Neus
  • M. Albaiceta, Guillermo
  • CRUZADO, JOSEP M
  • Serrano, Manuel
We are grateful to K. Raj (Altos Laboratories) for his help with the experiments on replicative senescence. We thank D. Muñoz Espin (University of Cambridge) for sending us the IMR90 cells stably transduced with tamoxifen inducible Ras-G12V. We thank R. Mendez (IRB) for the H5V and HUVEC cells. We thank staf at the TEM-SEM Electron Microscopy Unit from Scientific and Technological Centers (CCiTUB), Universitat de Barcelona for their support and advice on TEM techniques. We are thankful to the Magnetic Resonance Imaging Core Facility of the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) for the scientific and technical support in MRI acquisition and analysis. M.M. received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement (no. 794744) and from the Spanish Ministry of Science and Innovation (MCIN) (RYC2020-030652-/AEI/10.13039/501100011033). V.L.P. was a recipient of a predoctoral contract from the Spanish Ministry of Education (FPU-18/05917). K.M. was a recipient of fellowships from the German Cardiac, the German Research Foundation and a postdoctoral contract Juan de la Cierva from the MCIN. F.H.G. was supported by the PhD4MD Collaborative Research Training Program for Medical Doctors (IRB Barcelona/Hospital Clinic/IDIBAPS). M. Sanchez was funded by grants PID2021-122436OB-I00 from MCIN/AEI/10.13039/501100011033/FEDER, UE, RETOS COLABORACION RTC2019-007074-1 from MCIN/AEI/10.13039/501100011033. C.L.-M. was a recipient of a predoctoral contract from the Spanish Ministry of Education (FPU-18/02965). G.A. was funded by the Instituto de Salud Carlos III through project PI 20/01360, FEDER funds. J.M.C. was funded by the Instituto de Salud Carlos III through projects PI18/00910 and PI21/00931 (co-funded by European Regional Development Fund, a way to build Europe) and thanks the CERCA Programme/Generalitat de Catalunya for institutional support. Work in the laboratory of M. Serrano was funded by the IRB and ‘laCaixa’ Foundation and by grants from the Spanish Ministry of Science co-funded by the European Regional Development Fund (SAF2017-82613-R), European Research Council (ERC-2014-AdG/669622) and grant RETOS COLABORACION RTC2019-007125-1 from MCIN/AEI and Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282)., Fibrogenesis is part of a normal protective response to tissue injury that can become irreversible and progressive, leading to fatal diseases. Senescent cells are a main driver of fibrotic diseases through their secretome, known as senescence-associated secretory phenotype (SASP). Here, we report that cellular senescence, and multiple types of fibrotic diseases in mice and humans are characterized by the accumulation of iron. We show that vascular and hemolytic injuries are efficient in triggering iron accumulation, which in turn can cause senescence and promote fibrosis. Notably, we find that senescent cells persistently accumulate iron, even when the surge of extracellular iron has subdued. Indeed, under normal conditions of extracellular iron, cells exposed to different types of senescence-inducing insults accumulate abundant ferritin-bound iron, mostly within lysosomes, and present high levels of labile iron, which fuels the generation of reactive oxygen species and the SASP. Finally, we demonstrate that detection of iron by magnetic resonance imaging might allow non-invasive assessment of fibrotic burden in the kidneys of mice and in patients with renal fibrosis. Our findings suggest that iron accumulation plays a central role in senescence and fibrosis, even when the initiating events may be independent of iron, and identify iron metabolism as a potential therapeutic target for senescence-associated diseases., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Higher circulating vitamin B12 is associated with lower levels of inflammatory markers in individuals at high cardiovascular risk and in naturally aged mice

  • Domínguez-López, Inés
  • Kovatcheva, Marta
  • Casas, Rosa
  • Toledo, Estefania
  • Fitó Colomer, Montserrat
  • Ros, Emilio
  • Estruch, Ramón
  • Serrano, Manuel
  • Lamuela Raventós, Rosa Ma.
Background: Vitamin B12 is an essential nutrient that is involved in numerous physiological processes, and its deficiency can lead to various complications, including neurological and haematological disorders. Some studies have suggested that vitamin B12 may have anti-inflammatory effects, but the mechanisms underlying this relationship are not yet fully understood. We investigated the relationship between circulating vitamin B12 and inflammatory markers interleukin (IL)-6 and C-reactive protein (CRP). The association of peripheral levels of vitamin B12 with IL-6 and CRP was assessed in 136 human samples from a high cardiovascular risk population. To corroborate the results from the human trial, the analysis was replicated in naturally aged mice. Results: Individuals with higher serum levels of vitamin B12 showed lower concentrations of IL-6 and CRP after adjustment for potential confounders, and an inverse association was also found between serum IL-6 and vitamin B12 levels in naturally aged mice. Conclusion: Circulating vitamin B12 was inversely associated with IL-6 and CRP in humans and with IL-6 in mice, suggesting that it may exert an anti-inflammatory effect through modulation of these pro-inflammatory molecules. © 2023 The Authors. Journal of The Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry., This research was partially funded by PID2020-114022RB-I00 and CIBEROBN from the Instituto de Salud Carlos III, ISCIII from the Ministerio de Ciencia, Innovación y Universidades (AEI/FEDER, UE) and Generalitat de Catalunya (GC) [2021-SGR-00334]. INSA-UB is María de Maeztu Unit of Excellence (grant CEX2021-001234-M funded by MICIN/AEI/FEDER, UE). Work in the laboratory of M. Serrano was funded by the IRB and La Caixa Foundation, and by grants from the Spanish Ministry of Science cofunded by the European Regional Development Fund (SAF-2017-82613-R, RTC-2017-6123-1), the European Research Council (ERC-2014-AdG/669622), Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement of Catalonia (Grup de Recerca consolidat 2017 SGR 282) and the AECC (PRYCO211023SERR). M. Kovatcheva reports grants from Asociación Española Contra el Cáncer (AECC), the European Research Council and IRB BioMedTec during the conduct of the study, as well as other support from Galapagos NV outside the submitted work. M. Serrano reports grants from the Spanish Ministry of Science, the European Research Council, La Caixa Foundation, the Spanish Association for Cancer Research (AECC) and Departament d'Empresa i Coneixement of Catalonia during the conduct of the study, as well as other support from Senolytic Therapeutics, Inc., Rejuveron Senescence Therapeutics, AG, Life Biosciences, Inc., Altos Labs, Inc. and Galapagos NV, and grants from the Milky Way Research Foundation outside the submitted work. The PREDIMED trial was supported by the official funding agency for biomedical research of the Spanish government (Instituto de Salud Carlos III) through grants provided to research networks specifically developed for the trial: RTIC G03/140 (Coordinator: RE) and RTIC RD 06/0045. All investigators of the PREDIMED trial belong to Centro de Investigación Biomédica en Red (CIBER), an initiative of Instituto de Salud Carlos III. ID-L thanks the Spanish Ministry of Science Innovation and Universities for the Formación de Profesorado Universitario (FPU20/02478) contract.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

MED15 prion-like domain forms a coiled-coil responsible for its amyloid conversion and propagation

  • Batlle Carreras, Cristina|||0000-0003-4903-831X
  • Calvo, Isabel|||0000-0003-4107-296X
  • Iglesias, Valentin|||0000-0002-6133-0869
  • J. Lynch, Cian
  • Gil-Garcia, Marcos|||0000-0002-7457-7860
  • Serrano, Manuel|||0000-0001-7177-9312
  • Ventura, Salvador|||0000-0002-9652-6351
A disordered to β-sheet transition was thought to drive the functional switch of Q/N-rich prions, similar to pathogenic amyloids. However, recent evidence indicates a critical role for coiled-coil (CC) regions within yeast prion domains in amyloid formation. We show that many human prion-like domains (PrLDs) contain CC regions that overlap with polyQ tracts. Most of the proteins bearing these domains are transcriptional coactivators, including the Mediator complex subunit 15 (MED15) involved in bridging enhancers and promoters. We demonstrate that the human MED15-PrLD forms homodimers in solution sustained by CC interactions and that it is this CC fold that mediates the transition towards a β-sheet amyloid state, its chemical or genetic disruption abolishing aggregation. As in functional yeast prions, a GFP globular domain adjacent to MED15-PrLD retains its structural integrity in the amyloid state. Expression of MED15-PrLD in human cells promotes the formation of cytoplasmic and perinuclear inclusions, kidnapping endogenous full-length MED15 to these aggregates in a prion-like manner. The prion-like properties of MED15 are conserved, suggesting novel mechanisms for the function and malfunction of this transcription coactivator.